Why the study?
Does the development of significant proteinuria after conversion to mTOR-based immunosuppression predict poor outcomes in cardiac transplant recipients?
Does the development of significant proteinuria after conversion to mTOR-based immunosuppression predict poor outcomes in cardiac transplant recipients?
Significant proteinuria following conversion to mTOR inhibitors in cardiac transplant recipients indicates a risk for poor outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Howard J. Eisen (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: